Americas · Markets & Finance · BNN Bloomberg
Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis
Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company focused on developing innovative therapies and technologies, today announced…
Read the full article on BNN Bloomberg Sign in to saveMediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bnnbloomberg.ca)
